Therapeutic Alliance in Antidepressant Treatment: Cause or Effect of Symptomatic Levels? | Zendy

Sigal ZilchaMano | Zendy; Steven P. Roose | Zendy; Jacques P. Barber | Zendy; Bret R. Rutherford | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Therapeutic Alliance in Antidepressant Treatment: Cause or Effect of Symptomatic Levels?

Author(s) -

Sigal ZilchaMano,

Steven P. Roose,

Jacques P. Barber,

Bret R. Rutherford

Publication year - 2015

Publication title -

psychotherapy and psychosomatics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.531

H-Index - 98

eISSN - 1423-0348

pISSN - 0033-3190

DOI - 10.1159/000379756

Subject(s) - alliance , placebo , psychology , psychopharmacology , randomized controlled trial , psychiatry , antidepressant , clinical psychology , depression (economics) , medicine , anxiety , alternative medicine , pathology , political science , law , economics , macroeconomics

Previous studies have shown that in psychotherapy alliance is a predictor of symptomatic change, even while accounting for the temporal precedence between alliance and symptoms. However, the extent to which alliance predicts outcomes in psychopharmacology is yet to be fully investigated considering the fact that alliance can be the result, rather than the cause, of symptomatic change. The current prospective study examined whether the alliance predicts outcomes in psychopharmacology, while controlling for previous symptomatic change throughout the course of treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research